“`html
Key Points
Investors are increasingly focused on technology giants such as Nvidia, Apple, and Microsoft, which have all surpassed a market capitalization of $1 trillion. In 2023, Berkshire Hathaway also reached this milestone, but Eli Lilly, currently valued at approximately $904 billion, is predicted to join the club by 2026 as the weight loss drug market grows from $28 billion to an estimated $100 billion.
Eli Lilly’s significant revenue growth, attributed to its weight loss drugs like Mounjaro and Zepbound, achieved a 54% increase in the most recent quarter. The introduction of their oral weight loss candidate orforglipron, expected to file for regulatory review by the end of 2023, could further propel their market value.
Goldman Sachs Research forecasts the weight loss drug market will substantially increase, positioning Eli Lilly for continued growth and potential long-term stability in the trillion-dollar club.
“`
